Related Experiment Video
Updated: Jun 23, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Biological reactive intermediates that mediate dacarbazine cytotoxicity
Jalal Pourahmad1, Marzieh Amirmostofian, Farzad Kobarfard
1Faculty of Pharmacy, Shaheed Beheshti University of Medical Sciences, Tehran, PO Box 14155-6153, Iran. j.pourahmadjaktaji@utoronto.ca
Purpose:
In the following, the cellular and molecular mechanism of cytotoxicity induced by prodrug dacarbazine toward the isolated rat hepatocytes was studied.
Method:
Accelerated cytotoxicity screening technique (ACMS) was used to perform this study.
Result:
Addition of dacarbazine to isolated rat hepatocytes resulted in reactive oxygen species (ROS) formation, and lysosomal membrane leakiness before hepatocyte lysis occurred. Hepatocyte ROS generation was inhibited by desferoxamine (a ferric chelator). Cytotoxicity was prevented by antioxidants or ROS scavengers (mannitol or dimethylsulfoxide), cytochorome P450 inhibitors (phenylimidazole, diphenyliodonium chloride, 4-methylpyrazole, and benzylimidazole). In addition to lysosomal damage, dacarbazine caused hepatocyte protease activation and cell proteolysis.
Conclusion:
Dacarbazine cytotoxicity is associated with ROS (H(2)O(2), O(2)(*-) ) generation. It is suggested that H(2)O(2) could cross the lysosomal membrane, react with lysosomal Fe(2+) to form hydroxyl radical (Haber-Weiss reaction) which is the major cause of lysosomal membrane leakiness, proteases, and other digestive enzymes' release and finally the cell death.
Insights
Dacarbazine causes liver cell damage by generating reactive oxygen species (ROS) and damaging lysosomes. Antioxidants and cytochrome P450 inhibitors protect against this dacarbazine-induced hepatotoxicity.
Area of Science:
- Hepatology
- Toxicology
- Biochemistry
Background:
- Dacarbazine is a chemotherapy drug.
- Understanding its mechanism of liver cell toxicity is crucial for patient safety.
Purpose of the Study:
- To investigate the cellular and molecular mechanisms of dacarbazine-induced cytotoxicity in isolated rat hepatocytes.
Main Methods:
- Utilized the Accelerated Cytotoxicity Screening (ACMS) technique.
- Investigated the role of reactive oxygen species (ROS), lysosomal integrity, and cytochrome P450 enzymes.
Main Results:
- Dacarbazine induced ROS formation and lysosomal membrane leakiness preceding hepatocyte lysis.
- ROS generation was linked to iron and inhibited by chelators and antioxidants.
- Cytochrome P450 inhibitors also prevented dacarbazine cytotoxicity.
- Dacarbazine triggered protease activation and proteolysis within hepatocytes.
Conclusions:
- Dacarbazine cytotoxicity is mediated by ROS (H2O2, O2*-) generation.
- H2O2 may react with lysosomal iron, causing membrane damage and enzyme release, leading to cell death.
Related Concept Videos
Mutagenicity and Carcinogenicity
Bioactivation and Tissue Toxicity
Treatment Resistant Cancers
Drug Toxicity: Dose-Dependent Reactions
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

